We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry: EMA Call for Reevaluations of Children’s Meds Unwarranted
Industry: EMA Call for Reevaluations of Children’s Meds Unwarranted
January 16, 2013
The European Medicines Agency (EMA) has published new draft guidelines on pediatric drug development that require regular reevaluations of approved drug products.